Deep Dive: Deep Dive Into Decentralizing Clinical Trials

COVID-19 has extended its tentacles to all things in the medical field including how clinical trials are performed. This can be seen in how the COVID-19 vaccine trials moved these towards decentralization. Listen in how the move towards decentralization has benefits for industry and patients alike. Also, Dr. Owen Garrick, Chief Medical Officer of CVS Health Clinical Trial Services, offers some insights to achieving greater diversity overall in studies.